People channel feed

Scoop: Re­silience re­ceives Form 483 due to mold at Cana­di­an site, more lay­offs an­tic­i­pat­ed

Last year
FDA+
Manufacturing

Ex­clu­sive: Roger Perl­mut­ter on the biggest prob­lem in Big Phar­ma, leav­ing Mer­ck, and build­ing Eikon

Last year
Startups
R&D

Bio­Marin strikes co­op­er­a­tion deal with ac­tivist in­vestor El­liott, sets up re­view com­mit­tee and adds board mem­bers

Last year
Pharma

Scoop: Re­silience down­sizes tech­ni­cal R&D and qual­i­ty as­sur­ance di­vi­sions

Last year
Manufacturing

Aclaris halves head­count, banks on next mid-stage read­out af­ter clin­i­cal set­backs tanked shares

Last year

Ver­i­ly’s chief med­ical of­fi­cer Amy Aber­nethy is step­ping down

Last year
Health Tech

Q&A: JP Mor­gan’s new life sci­ences pri­vate cap­i­tal leader on the bank’s ex­pand­ing am­bi­tions, vet­ting star­tups and Abu Dhabi’s biotech push

Last year
Financing

Pub­li­cis Health names new chief ex­ec­u­tive from its agency net­work

Last year
Marketing

Jay Brad­ner joins Am­gen to lead R&D as David Reese moves to new chief tech­nol­o­gy of­fi­cer role

Last year
R&D

Ex­clu­sive: Renowned im­munol­o­gy leader 'Skip' Vir­gin is out as Al­tos Labs med­ical chief

Last year

Vir down­sizes by 12%, will close St. Louis and Port­land sites in 2024 to save $40M+ an­nu­al­ly

Last year

UMass med­ical school’s man­u­fac­tur­ing busi­ness trims 36 po­si­tions

Last year
Manufacturing

Mod­er­na's chief com­mer­cial of­fi­cer out as com­pa­ny re­or­ga­nizes

Last year
Marketing

Fer­ring Phar­ma­ceu­ti­cals lays off 134 em­ploy­ees be­tween NJ and MN lo­ca­tions

Last year
Pharma

Ex­clu­sive: Aviv Regev talks three years of lead­ing Genen­tech’s re­search, the fu­ture of AI, and not mak­ing No­bel pre­dic­tions

Last year
R&D
AI

Bris­tol My­ers’ lead deal ne­go­tia­tor to de­part af­ter ink­ing se­ries of multi­bil­lion-dol­lar ac­qui­si­tions

Last year
Pharma

Three big win­ners from Ab­b­Vie's $8.7B Cerev­el deal: A drug­mak­er, a CEO and a SPAC

Last year
Deals
Pharma

NASH drug­mak­er He­p­i­on to seek strate­gic al­ter­na­tives

Last year
Pharma

IGM Bio­sciences cuts 22% of work­force, ax­es hema­to­log­ic on­col­o­gy pro­gram

Last year
R&D

Scoop: Res­o­nance Med­i­cine, a pro­tease biotech from David Liu’s lab, shuts down

Last year
Startups

BIO names its vice chair and Am­i­cus founder John Crow­ley as next CEO

Last year

Tra­vere plans to lay off 20% of work­force as it fo­cus­es on full ap­proval for kid­ney dis­ease drug

Last year

An­oth­er Flag­ship-found­ed biotech shut­ters as Ax­cel­la liq­ui­dates, end­ing long Covid plans

Last year
R&D

Or­na Ther­a­peu­tics trims staff in ‘de­fen­sive re­duc­tion’ de­spite large fi­nanc­ing hauls

Last year
Startups
Cell/Gene Tx
First page Previous page 16171819202122 Next page Last page
A service from the Financial Times